Abstract

Radiotherapy (RT) serves as an important adjuvant treatment. Pathological findings classify cervical cancer patients who undergo an upfront radical hysterectomy into low-, intermediate-, and high-risk groups. For low-risk groups, evidence-based guidelines recommend no adjuvant treatment, for intermediate-risk groups, adjuvant RT and chemotherapy, and for high-risk groups, adjuvant RT and chemotherapy. Resected endometrial cancer is treated with RT, chemotherapy, or both, depending on the tumor's stage and histologic grade.